Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental Vitiligo

NCT07181187 is registered in ClinicalTrials.gov with Minghui Pharmaceutical (Hangzhou) Ltd as lead sponsor.

NCT NCT07181187
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07181187 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental Vitiligo
Lead sponsor
Minghui Pharmaceutical (Hangzhou) Ltd
Phase
Phase 2
Overall status
Completed
Start date
March 26, 2024
Completion date
May 7, 2026
Enrollment
156 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vitiligo